MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 165601 to 165620 of 166,322 approvalsPage 8281 of 8317

Oxygen

Approval Number: 国药准字H20193220
Registration: Aug 2, 2019

Oxygen

Approval Number: 国药准字H20193221
Registration: Aug 2, 2019

Rivaroxaban Tablets

Approval Number: 国药准字H20193225
Registration: Aug 2, 2019

Insulin Lispro Injection

Approval Number: S20191011
Registration: Aug 1, 2019

Insulin Lispro Injection

Approval Number: S20191010
Registration: Aug 1, 2019

Insulin Lispro Injection

Approval Number: S20191009
Registration: Aug 1, 2019

Lyophilizing Thrombin Powder

Approval Number: 国药准字H22023388
Registration: Jul 31, 2019

Inosine Injection

Approval Number: 国药准字H22025657
Registration: Jul 31, 2019

Lyophilizing Thrombin Powder

Approval Number: 国药准字H22023387
Registration: Jul 31, 2019

Berberine Hydrochloride Tablets

Approval Number: 国药准字H42020935
Registration: Jul 30, 2019

Glucosamine Sulfate Effervescent Tablets

Approval Number: 国药准字H20090310
Registration: Jul 29, 2019

盐酸安非他酮

Approval Number: 国药准字H20080377
Registration: Jul 29, 2019

淫羊藿总黄酮提取物

Approval Number: 国药准字Z20140011
Registration: Jul 29, 2019

Raltitrexed for Injection

Approval Number: 国药准字H20090325
Registration: Jul 29, 2019

Docetaxel Injection

Approval Number: 国药准字H20093850
Registration: Jul 29, 2019

Norfloxacin Capsules

Approval Number: 国药准字Z20093709
Registration: Jul 29, 2019

Aztreonam for Injection

Approval Number: 国药准字H20093847
Registration: Jul 29, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.